Open Access
Subscription or Fee Access
Plasma Therapy as a Last Resort in Combating COVID-19?
Abstract
This study aims to provide some insights into the current pandemic situation of COVID-19 and its proposed cure in the form of convalescent plasma (CP) therapy. This article is prepared using information from various research papers available online. The findings are concluded with the point that the convalescent plasma therapy is although functional in the early stages, is much important in critical cases where the patient is suffering from SARS CoV in the final stage along with drug administration, convalescent plasma therapy cannot alone cure the disease but can help subside the lethality.
Keywords
References
WHO | SARS (Severe Acute Respiratory Syndrome) [Internet]. WHO. [cited 2020 May 23]. Available from: https://www.who.int/ith/diseases/sars/en/
Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats Are Natural Reservoirs of SARS-Like Coronaviruses. Science. 2005 Oct 28; 310(5748): 676–9p.
Yang L, Wu Z, Ren X, Yang F, He G, Zhang J, et al. Novel SARS-like Betacoronaviruses in Bats, China, 2011. Emerg Infect Dis. 2013 Jun; 19(6): 989–91p.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New Eng J Med. 2020 Feb 20; 382(8): 727–33p.
WHO_HIS_SDS_2014.8_eng.pdf [Internet]. [cited 2020 May 22]. Available from: https://apps.who.
int/iris/bitstream/handle/10665/135591/WHO_HIS_SDS_2014.8_eng.pdf
Burnouf T, Seghatchian J. Ebola Virus Convalescent Blood Products: Where We are Now and Where We may Need to Go. Transfusion Apheresis Sci. 2014 Oct 1; 51(2): 120–5p.
Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, et al. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea. J Korean Med Sci [Internet]. 2020 Apr 6 [cited 2020 May 22; 35(14). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152526/
Rojas M, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y, Camacho B, Gallo JE, et al. Convalescent Plasma in COVID-19: Possible Mechanisms of Action. Autoimmun Rev. 2020 May 5; 102554.
Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A. Convalescent Plasma Transfusion for the Treatment of COVID-19: Systematic Review. J Med Virol [Internet]. 2020 May 1 [cited 2020 May 22]; n/a(n/a). Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25961
Teixeira da Silva JA. Convalescent plasma: A Possible Treatment of COVID-19 in India. Med J Armed Forces India [Internet]. 2020 Apr 15 [cited 2020 May 22]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158785/
Marano G, Vaglio S, Pupella S, Facco G, Catalano L, Liumbruno GM, et al. Convalescent Plasma: New Evidence for an Old Therapeutic Tool? Blood Transfus. 2016 Mar; 14(2): 152–7p.
Luke TC, Casadevall A, Watowich SJ, Hoffman SL, Beigel JH, Burgess TH. Hark Back: Passive Immunotherapy for Influenza and Other Serious Infections. Crit Care Med. 2010 Apr; 38: e66.
Wang S-F, Tseng S-P, Yen C-H, Yang J-Y, Tsao C-H, Shen C-W, et al. Antibody-dependent SARS Coronavirus Infection is Mediated by Antibodies against Spike Proteins. Biochem Biophys Resh Commun. 2014 Aug 22; 451(2): 208–14p.
Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of Convalescent Plasma Therapy in Severe COVID-19 Patients. Proc Natl Acad Sci USA. 2020 Apr 28; 117(17): 9490–6p.
Chen L, Xiong J, Bao L, Shi Y. Convalescent Plasma as a Potential Therapy for COVID-19. Lancet Infect Dis. 2020 Apr 1; 20(4): 398–400p.
Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma. JAMA. 2020 Apr 28; 323(16): 1582–9p.
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A Pneumonia Outbreak associated with a New Coronavirus of Probable Bat Origin. Nature. 2020 Mar; 579(7798): 270–3p.
Brown BL, McCullough J. Treatment for Emerging Viruses: Convalescent Plasma and COVID-19. Transfusion and Apheresis Science [Internet]. 2020 Apr 20 [cited 2020 May 22]; 0(0). Available from: https://www.trasci.com/article
/S1473-0502(20)30079-3/abstract
Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, et al. Deployment of Convalescent Plasma for the Prevention and Treatment of COVID-19. J Clin Invest [Internet]. 2020 Apr 7 [cited 2020 May 22]; Available from: https://www.jci.org/
articles/view/138745
Zeng Q-L, Yu Z-J, Gou J-J, Li G-M, Ma S-H, Zhang G-F, et al. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019. J Infect Dis [Internet]. [cited 2020 May 22]; Available from: https://academic.oup.
com/jid/advance-article/doi/10.1093
/infdis/jiaa228/5826985
Casadevall A, Pirofski L. The Convalescent Sera Option for Containing COVID-19. J Clin Invest. 2020 Apr 1; 130(4): 1545–8p.
Ay P, Ap H, Dd S, Rs B, Dv D, Ys A. Convalescent Plasma: A Possible Treatment Protocol for COVID- 19 Patients Suffering from Diabetes or Underlying Liver Diseases. Diabetes Metab Syndr [Internet]. 2020 May 14 [cited 2020 May 22]; Available from: https://europepmc.org/article/pmc/pmc7214325
Wieding JU, Hellstern P, Köhler M. Inactivation of Viruses in Fresh-frozen Plasma. Ann Hematol. 1993 Dec 1; 67(6): 259–66p.
Lisboa LF, Åsberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, et al. The Clinical Utility of Whole Blood Versus Plasma Cytomegalovirus Viral Load Assays for Monitoring Therapeutic Response. Transplantation. 2011 Jan 27; 91(2): 231–236p.
Research C for BE and. Recommendations for Investigational COVID-19 Convalescent Plasma. FDA [Internet]. 2020 May 1 [cited 2020 May 22]; Available from: https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma
DOI: https://doi.org/10.37591/rrjomv.v11i1.2253
Refbacks
- There are currently no refbacks.